P. Edith Mitchell's most recent trade in Corvus Pharmaceuticals Inc was a trade of 15,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 6, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Corvus Pharmaceuticals Inc | P. Edith Mitchell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2023 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Corvus Pharmaceuticals Inc | Edith P. Mitchell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Corvus Pharmaceuticals Inc | Edith P. Mitchell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Corvus Pharmaceuticals Inc | Edith P. Mitchell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Corvus Pharmaceuticals Inc | Edith P. Mitchell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2021 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Corvus Pharmaceuticals Inc | Edith P. Mitchell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2020 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) |